JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB181871

Anti-Von Willebrand Factor antibody [EPR2992(N)]

5

(1 Review)

|

(2 Publications)

Rabbit Recombinant Monoclonal Von Willebrand Factor antibody. Suitable for IP, WB and reacts with Human samples. Cited in 2 publications.

View Alternative Names

F8VWF, VWF, von Willebrand factor, vWF

2 Images
Immunoprecipitation - Anti-Von Willebrand Factor antibody [EPR2992(N)] (AB181871)
  • IP

Supplier Data

Immunoprecipitation - Anti-Von Willebrand Factor antibody [EPR2992(N)] (AB181871)

Western blot analysis on immunoprecipitation pellet from Human plasma, labeling Von Willebrand Factor immunoprecipitated using ab181871 at 1/70 dilution and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.

All lanes:

Immunoprecipitation - Anti-Von Willebrand Factor antibody [EPR2992(N)] (ab181871)

Predicted band size: 309 kDa

false

Western blot - Anti-Von Willebrand Factor antibody [EPR2992(N)] (AB181871)
  • WB

Supplier Data

Western blot - Anti-Von Willebrand Factor antibody [EPR2992(N)] (AB181871)

All lanes:

Western blot - Anti-Von Willebrand Factor antibody [EPR2992(N)] (ab181871) at 1/2000 dilution

Lane 1:

Human plasma lysate at 20 µg

Lane 2:

Human serum lysate at 20 µg

Lane 3:

HepG2 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 309 kDa

Observed band size: 309 kDa

false

  • Carrier free

    Anti-Von Willebrand Factor antibody [EPR2992(N)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2992(N)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/70", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.
See full target information VWF

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Discover oncology 15:333 PubMed39095628

2024

DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family.

Applications

Unspecified application

Species

Unspecified reactive species

Shaohan Wu,Xiaofang Sun,Ruheng Hua,Chundong Hu,Lei Qin

Frontiers in neurology 11:549624 PubMed33117257

2020

Serum Protein Biomarker Findings Reflective of Oxidative Stress and Vascular Abnormalities in Male, but Not Female, Collision Sport Athletes.

Applications

Unspecified application

Species

Unspecified reactive species

Brendan P Major,Stuart J McDonald,William T O'Brien,Georgia F Symons,Meaghan Clough,Daniel Costello,Mujun Sun,Rhys D Brady,Jesse Mccullough,Roxanne Aniceto,I-Hsuan Lin,Meng Law,Richelle Mychasiuk,Terence J O'Brien,Denes V Agoston,Sandy R Shultz
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com